WASHINGTON (September 11, 2013)--The U.S. Food and Drug Administration said Wednesday that Allergan's Botox Cosmetic injection is the first drug approved to treat crow’s feet, the wrinkles that form on the outside edge of the eyes.
Allergan Inc. studied use of the drug in 833 adults with crow's feet who randomly received Botox or a sham injection.
Patients who received Botox had fewer visible wrinkles than those who received the placebo drug.
The most common side effects seen in patients were swelling and excess liquid around the eyelids.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.